GE HealthCare and Mayo Clinic Launch GEMINI-RT to Advance Personalized Radiation Therapy
GE HealthCare and Mayo Clinic have announced GEMINI-RT, a new research initiative aimed at advancing personalized radiation therapy through deeper integration of imaging, artificial intelligence (AI), and patient monitoring. This collaboration builds upon their long-standing partnership and follows a 2023 research agreement centered on innovations in radiology and oncology.
GEMINI-RT combines GE HealthCare’s engineering capabilities with the Mayo Clinic’s clinical expertise to enhance prediction, planning, automation, and monitoring in radiation therapy. According to leaders from both organizations, the program intends to examine how imaging, dosimetry, advanced therapies, and connected care tools can be aligned across a patient’s entire treatment journey.
Radiation therapy remains central to cancer treatment, used in more than half of cases worldwide. Rising cancer incidence continues to increase demand, underscoring the need for more efficient and personalized care models. GEMINI-RT aims to address these challenges by applying data-driven approaches to better anticipate patient needs and refine treatment decisions.
Bryan Traughber, M.D., vice chair of innovation for radiation oncology at Mayo Clinic, said the initiative builds on the concept of “twinning the patient, personalizing the beam.” He noted that combining Mayo Clinic’s outcomes data with GE HealthCare’s technology “could allow us to model individual patient journeys with precision, enabling radiation therapy treatments that are truly tailored to each patient.”
The collaboration will focus on four areas: automating repetitive clinical tasks with AI, enhancing predictive tools for treatment planning, exploring multimodal therapy combinations, and developing connected care technologies for monitoring patients outside the clinic. Ben Newton, GE HealthCare’s global head of oncology, said these efforts aim to improve the clinical experience, reduce burdens on care teams, and support high-quality patient care.
Research activities under GEMINI-RT will be based at the Rochester campus of the Mayo Clinic, drawing on the strengths of both organizations in oncology, product development, and translational research.
